tiprankstipranks
Trending News
More News >
Medicamen Biotech Limited (IN:MEDICAMEQ)
:MEDICAMEQ
India Market

Medicamen Biotech Limited (MEDICAMEQ) Financial Statements

Compare
0 Followers

Medicamen Biotech Limited Financial Overview

Medicamen Biotech Limited's market cap is currently ₹5.47B. The company's EPS TTM is ₹1.47; its P/E ratio is 78.19; and it has a dividend yield of 0.25%. Medicamen Biotech Limited is scheduled to report earnings on May 30, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 1.63B₹ 1.79B₹ 1.41B₹ 1.15B₹ 1.13B
Gross Profit₹ 389.90M₹ 852.01M₹ 687.74M₹ 479.88M₹ 335.16M
Operating Income₹ 67.92M₹ 516.84M₹ 176.32M₹ 178.96M₹ 168.25M
EBITDA₹ 201.02M₹ 245.66M₹ 277.12M₹ 258.07M₹ 204.25M
Net Income₹ 71.08M₹ 109.31M₹ 148.44M₹ 148.98M₹ 121.29M
Balance Sheet
Cash & Short-Term Investments₹ 37.59M₹ 147.86M₹ 207.79M₹ 38.25M₹ 16.57M
Total Assets₹ 2.97B₹ 2.95B₹ 2.79B₹ 2.26B₹ 1.94B
Total Debt₹ 332.53M₹ 311.12M₹ 241.83M₹ 257.96M₹ 188.19M
Net Debt₹ 294.94M₹ 163.26M₹ 34.04M₹ 219.71M₹ 171.63M
Total Liabilities₹ 841.04M₹ 875.67M₹ 851.03M₹ 792.24M₹ 611.18M
Stockholders' Equity₹ 2.13B₹ 2.07B₹ 1.93B₹ 1.46B₹ 1.33B
Cash Flow
Free Cash Flow₹ -119.32M₹ -130.31M₹ -128.94M₹ -44.99M₹ -51.94M
Operating Cash Flow₹ -98.59M₹ -67.44M₹ -62.93M₹ 41.09M₹ 127.72M
Investing Cash Flow₹ -23.78M₹ -55.63M₹ -58.80M₹ -84.73M₹ -178.13M
Financing Cash Flow₹ 12.16M₹ 63.13M₹ 291.27M₹ 42.98M₹ 58.39M
Currency in INR

Medicamen Biotech Limited Earnings and Revenue History

Medicamen Biotech Limited Debt to Assets

Medicamen Biotech Limited Cash Flow

Medicamen Biotech Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis